Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
CD26 is a lymphocyte cell surface antigen which is increased during T-cell activation and is also expressed in other tissues. It is an atypical serine protease belonging to the prolyl oligopeptidase family. CD26 has been implicated in a variety of biological functions including T-cell activation, cell-to-cell adhesion, and recently in HIV infection. This paper describes, through the isolation and partial sequencing of eight human CD26 genomic clones, the first information on the genomic organization of the prolyl oligopeptidase family. We have established that the human CD26 gene spans approximately 70 kilobases (kb) and contains 26 exons, ranging in size from 45 base pairs (bp) to 1.4 kb. The nucleotides that encode the serine recognition site (G-W-S-Y-G) are split between two exons. This clearly distinguishes the genomic organization of the prolyl oligopeptidase family from that of the classical serine protease family. The 5' flanking domain of the CD26 gene contains neither a TATA box nor a CAAT box, but a 300 bp region extremely rich in C and G (72%) contains potential binding sites for several transcriptional factors. The human CD26 gene encodes two messages sized at about 4.2 and 2.8 kb. These are both expressed at high levels in the placenta and kidney and at moderate levels in the lung and liver. Only the 4.2 kb mRNA was expressed at low levels in skeletal muscle, heart, brain, and pancreas. Fluorescence in situ hybridization on metaphase chromosome spreads located th…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regulation of DPPIV expression seems to be tissue specific, 28,29 and soluble antigen concentrations may reflect not only expression but also cleavage from the cell surface.”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [28]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Lee, W., Haslinger, A., Karin, M., & Tjian, R. (1987) · Nature · doi:10.1038/325368a0 · Cited by 731 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507 · cited 1×
“Furthermore, CD26 has been shown to bind adenosine deaminase ADA; (Morrison et al. 1993; Kameoka et al. 1993).”
SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements
Prestridge, D. S. (1991) · Bioinformatics · doi:10.1093/bioinformatics/7.2.203 · Cited by 489
Ishii, S., Xu, Y. H., Stratton, R. H., Roe, B. A., Merlino, G. T., & Pastan, I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4920 · Cited by 373
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325 · cited 2×
“The full spectrum of CD26 function remains unclear (Fleischer 1994).”
Human N-myc is closely related in organization and nucleotide sequence to c-myc
Kohl, N. E., Legouy, E., DePinho, R. A., Nisen, P. D., Smith, R. K., Gee, C. E., & Alt, F. W. (1986) · Nature · doi:10.1038/319073a0 · Cited by 274 · cited 1×
“Promoters of this type are known to regulate the expression of proto-oncogenes such as Pim 1, N-myc, or H-ras (Ishii et al. 1985 a; Kohl et al. 1986; Meeker et al. 1990) and growth factor receptors such as epidermal growth factor receptor (Ishii et al.”
Proline specific endo- and exopeptidases
Walter, R., Simmons, W., & Yoshimoto, T. (1980) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227927 · Cited by 256
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossmann, S. F., & Reinherz, E. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.3.1250 · Cited by 235
Ishii, S., Merlino, G. T., & Pastan, I. (1985) · Science · doi:10.1126/science.2999983 · Cited by 219
T Cell Activation Antigen, CD26, as a Cofactor for Entry of HIV in CD4 + Cells
Callebaut, C., Krust, B., Jacotot, E., & Hovanessian, A. G. (1993) · Science · doi:10.1126/science.7903479 · Cited by 219 · cited 1×
“New evidence suggests that CD26 acts as a cofactor for the entry of human immunodeficiency virus (HIV) into cells (Callebaut et al. 1993).”
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.2090 · Cited by 202
Ogata, S., Misumi, Y., & Ikehara, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94108-6 · Cited by 180
Piazza, G. A., Callanan, H. M., Mowery, J., & Hixson, D. C. (1989) · Biochemical Journal · doi:10.1042/bj2620327 · Cited by 178
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., & Morimoto, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.481 · Cited by 178
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F., & Morimoto, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4586 · Cited by 176
Dang, N. H., Torimoto, Y., Schlossman, S. F., & Morimoto, C. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.649 · Cited by 171
A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
Morrison, M. E., Vijayasaradhi, S., Engelstein, D., Albino, A. P., & Houghton, A. N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1135 · Cited by 170 · cited 1×
“Furthermore, CD26 has been shown to bind adenosine deaminase ADA; (Morrison et al. 1993; Kameoka et al. 1993).”
Flentke, G. R., Munoz, E., Huber, B. T., Plaut, A. G., Kettner, C. A., & Bachovchin, W. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1556 · Cited by 168 · cited 1×
“It is involved in the costimulation of T cells (Dang et al. 1990a, b; Flentke et al. 1991; Tanaka et al. 1993), binds to extracellular matrix proteins (Dang et al.”
The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.
Hegen, M., Niedobitek, G., Klein, C. E., Stein, H., & Fleischer, B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2908 · Cited by 167 · cited 2×
“CD26 is also expressed on the surface of epithelial and endothelial cells (Feller et al. 1986; Heike et al. 1988; Hegen et al. 1990; McCaughan et al. 1990) and is an atypical serine protease that cleaves N-terminal dipeptides from proteins with a proline or sometimes alanine at the penultimate position (Walter et al.”
Dang, N. H., Torimoto, Y., Deusch, K., Schlossman, S. F., & Morimoto, C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4092 · Cited by 142
Studies on glycyl-proline naphthylamidase
Lojda, Z. K. (1977) · Histochemistry and Cell Biology · doi:10.1007/bf00508273 · Cited by 124
Fountain, J. W., Bale, S. J., Housman, D. E., & Dracopoli, N. C. (1990) · PubMed · Cited by 124
Dang, N. H., Torimoto, Y., Sugita, K., Daley, J. F., Schow, P. W., Prado, C. M., Schlossman, S. F., & Morimoto, C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.3963 · Cited by 123
Misumi, Y., Hayashi, Y., Arakawa, F., & Ikehara, Y. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90036-y · Cited by 108 · cited 1×
“These two mRNAs correlate approximately with the two known human cDNA sequences (Misumi et al. 1992; Tanaka et al. 1992) which differ in sequence only at the 3' UT region.”
A transcription factor active on the epidermal growth factor receptor gene.
Kageyama, R., Merlino, G. T., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5016 · Cited by 101 · cited 1×
“There is an ETF site at position-239, which is known to regulate the expression of the epidermal growth factor receptor (Kageyama et al. 1988).”
Oligopeptidases, and the Emergence of the Prolyl Oligopeptidase Family
Barrett, A. J., & Rawlings, N. D. (1992) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1992.373.2.353 · Cited by 97 · cited 1×
“The structural homology of CD26 with other nonclassical serine proteases has assigned CD26 to the prolyl oligopeptidase family (Barrett and Rawlings 1992; Polgar and Szabo 1992).”
Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.
Ahmad, S., Wang, L., & Ward, P. E. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11437-7 · Cited by 95 · cited 1×
“Such actions are known to alter the biological activity of substance P (Ahmad et al. 1992), human growth hormone-releasing factor (Bongers et al.”
Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs
Bongers, J., LAMBROS, T. J., Ahmad, M., & Heimer, E. P. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90317-7 · Cited by 94 · cited 1×
“1992), human growth hormone-releasing factor (Bongers et al. 1992), and other bioactive peptides and proteins (Nausch et al.”
Johnson, R. C., Zhu, D., Augustin-Voss, H. G., & Pauli, B. U. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.6.1423 · Cited by 89 · cited 1×
“1989), and has recently been implicated in the attachment of cancer cells to lung endothelium (Johnson et al. 1993).”
Callen, D. F., Baker, E., Hj, E., Je, C., Ja, B., & Sutherland, G. R. (1990) · PubMed · Cited by 87
Self-citationThe Degradation of Bioactive Peptides and Proteins by Dipeptidyl Peptidase IV from Human Placenta
NAUSCH, I., MENTLEIN, R., & HEYMANN, E. (1990) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1990.371.2.1113 · Cited by 84
Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T‐Lymphocytes
MATTERN, T., SCHOLZ, W., FELLER, A. C., FLAD, H. ‐., & ULMER, A. J. (1991) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1991.tb02548.x · Cited by 76 · cited 1×
“This cell surface expression is increased significantly by T-cell activation (Gorrell et al. 1991; Mattern et al. 1991).”
McCaughan, G. W., Wickson, J. E., Creswick, P. F., & Gorrell, M. D. (1990) · Hepatology · doi:10.1002/hep.1840110403 · Cited by 73
Self-citationDavid, F., Bernard, A., Pierres, M., & Marguet, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85329-2 · Cited by 70
Expression of the rat CD26 Antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes
Gorrell, M. D., Wickson, J. E., & McCaughan, G. W. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90343-a · Cited by 69 · cited 1×
“This cell surface expression is increased significantly by T-cell activation (Gorrell et al. 1991; Mattern et al. 1991).”
Self-citationMeeker, T. C., Loeb, J., Ayres, M., & Sellers, W. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1680 · Cited by 67 · cited 1×
“Promoters of this type are known to regulate the expression of proto-oncogenes such as Pim 1, N-myc, or H-ras (Ishii et al. 1985 a; Kohl et al. 1986; Meeker et al. 1990) and growth factor receptors such as epidermal growth factor receptor (Ishii et al.”
Ogata, S., Misumi, Y., Tsuji, E., Takami, N., Oda, K., & Ikehara, Y. (1992) · Biochemistry · doi:10.1021/bi00124a019 · Cited by 67
Darmoul, D., Lacasa, M., Chantret, I., Swallow, D. M., & Trugnan, G. (1990) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1990.tb00377.x · Cited by 40
Kenny, A. J., Fulcher, I. S., McGill, K. A., & Kershaw, D. (1983) · Biochemical Journal · doi:10.1042/bj2110755 · Cited by 40 · cited 1×
“Exon 3 contains the area of the protein close to the cell surface which is easily cleaved at 39serine by papain and probably forms an extended stalk structure (Kenny et al. 1983).”
Heike, M., Möbius, U., Knuth, A. K., Meuer, S. C., & Büschenfelde, K. H. M. Z. (1988) · PubMed Central · Cited by 38
A monoclonal antibody detecting dipeptidylpeptidase IV in human tissue
Feller, A. C., Radzun, H., Heymann, E., Haas, H., Scholz, W. W., & Parwaresch, M. R. (1986) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00708333 · Cited by 22 · cited 1×
“CD26 is also expressed on the surface of epithelial and endothelial cells (Feller et al. 1986; Heike et al. 1988; Hegen et al. 1990; McCaughan et al. 1990) and is an atypical serine protease that cleaves N-terminal dipeptides from proteins with a proline or sometimes alanine at the penultimate position (Walter et al.”
Polgár, L., & Szabó, E. (1992) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1992.373.2.361 · Cited by 17
Cited by
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
“249–251 In vitro, DPP IV rapidly cleaves the N-terminal Tyr-Pro from NPY and PYY, resulting in NPY(3-36) and PYY(3-36).”
BackgroundInfluentialPharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
“In the mouse, Dpp4 is found on chromosome 2 (2C2–2D), and interestingly, exon 21 and exon 22 are present as a single 156-bp exon (19, 20).”
BackgroundInfluentialCD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Klemann, C., Wagner, L., Stephan, M., & von Hörsten, S. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12781 · Cited by 425
Metadata
- Authors
- Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R.
- Affiliations
- Royal Prince Alfred Hospital (AU)
- Women's and Children's Hospital (AU)
- Venue
- Immunogenetics
- Published
- 1994-09
- Volume
- 40
- Issue
- 5
- Pages
- 331-338
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2027150840
- Cited by
- 177
- References
- 46
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 2 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 5
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- CD26, dipeptidyl peptidase IV, gene structure, exon-intron organization, serine protease, T cell activation, tissue expression, 5'-flanking region, transcriptional regulatory elements, gene mapping, HIV infection
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 2, Cloning, Molecular, Exons, Humans, Introns, Male, Molecular Sequence Data, Restriction Mapping, DNA Probes, Genome, Dipeptidyl Peptidase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.